Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3–4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276)

Bone Marrow Transplantation, Published online: 30 May 2023; doi:10.1038/s41409-023-02005-4Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3–4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276)

Source: Bone Marrow Transplantation - May 30, 2023 Category: Hematology Authors: Fei Zhou Tingting Pan Xiaoli Li Feng Du Xiao Ma Yanming Zhang Depei Wu Yue Han Shengli Xue Miao Miao Tao Tao Xuefeng He Suning Chen Source Type: research